全文获取类型
收费全文 | 947篇 |
免费 | 61篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 39篇 |
妇产科学 | 13篇 |
基础医学 | 121篇 |
口腔科学 | 13篇 |
临床医学 | 80篇 |
内科学 | 218篇 |
皮肤病学 | 16篇 |
神经病学 | 133篇 |
特种医学 | 10篇 |
外科学 | 100篇 |
综合类 | 1篇 |
预防医学 | 67篇 |
眼科学 | 5篇 |
药学 | 60篇 |
中国医学 | 2篇 |
肿瘤学 | 126篇 |
出版年
2023年 | 5篇 |
2022年 | 13篇 |
2021年 | 23篇 |
2020年 | 14篇 |
2019年 | 20篇 |
2018年 | 16篇 |
2017年 | 27篇 |
2016年 | 14篇 |
2015年 | 20篇 |
2014年 | 30篇 |
2013年 | 56篇 |
2012年 | 73篇 |
2011年 | 73篇 |
2010年 | 34篇 |
2009年 | 38篇 |
2008年 | 71篇 |
2007年 | 62篇 |
2006年 | 72篇 |
2005年 | 56篇 |
2004年 | 68篇 |
2003年 | 57篇 |
2002年 | 64篇 |
2001年 | 15篇 |
2000年 | 7篇 |
1999年 | 10篇 |
1998年 | 8篇 |
1997年 | 7篇 |
1996年 | 7篇 |
1995年 | 8篇 |
1994年 | 4篇 |
1993年 | 6篇 |
1992年 | 5篇 |
1991年 | 6篇 |
1990年 | 5篇 |
1989年 | 4篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 2篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
排序方式: 共有1014条查询结果,搜索用时 15 毫秒
101.
Di Renzo F Cappelletti G Broccia ML Giavini E Menegola E 《Toxicology and applied pharmacology》2007,220(2):178-185
Histone deacetylases (HDAC) control gene expression by changing histonic as well as non histonic protein conformation. HDAC inhibitors (HDACi) are considered to be among the most promising drugs for epigenetic treatment for cancer. Recently a strict relationship between histone hyperacetylation in specific tissues of mouse embryos exposed to two HDACi (valproic acid and trichostatin A) and specific axial skeleton malformations has been demonstrated. The aim of this study is to verify if boric acid (BA), that induces in rodents malformations similar to those valproic acid and trichostatin A-related, acts through similar mechanisms: HDAC inhibition and histone hyperacetylation. Pregnant mice were treated intraperitoneally with a teratogenic dose of BA (1000 mg/kg, day 8 of gestation). Western blot analysis and immunostaining were performed with anti hyperacetylated histone 4 (H4) antibody on embryos explanted 1, 3 or 4 h after treatment and revealed H4 hyperacetylation at the level of somites. HDAC enzyme assay was performed on embryonic nuclear extracts. A significant HDAC inhibition activity (compatible with a mixed type partial inhibition mechanism) was evident with BA. Kinetic analyses indicate that BA modifies substrate affinity by a factor alpha=0.51 and maximum velocity by a factor beta=0.70. This work provides the first evidence for HDAC inhibition by BA and suggests such a molecular mechanism for the induction of BA-related malformations. 相似文献
102.
103.
Maksimovic-Ivanic D Mijatovic S Harhaji L Miljkovic D Dabideen D Fan Cheng K Mangano K Malaponte G Al-Abed Y Libra M Garotta G Nicoletti F Stosic-Grujicic S 《Molecular cancer therapeutics》2008,7(3):510-520
Preclinical studies have shown that nitric oxide (NO)-donating nonsteroidal anti-inflammatory drugs possess anticancer activities. Here, we report in vitro and in vivo studies showing the antitumor effect of the NO-donating isoxazole derivative (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid (GIT-27NO). GIT-27NO, but not the NO-deprived parental compound VGX-1027, significantly affected viability of both rodent (L929, B16, and C6) and human (U251, BT20, HeLa, and LS174) tumor cell lines. GIT-27NO triggered either apoptotic cell death (e.g., L929 cells) or autophagic cell death (C6 and B16 cells). Moreover, GIT-27NO hampered the viability of cisplatin-resistant B16 cells. NO scavenger hemoglobin completely prevented GIT-27NO-induced death, indicating that NO release mediated the tumoricidal effect of the compound. Increase in intracellular NO upon on the treatment was associated with intensified production of reactive oxygen species, whereas their neutralization by antioxidant N-acetylcysteine resulted in partial recovery of cell viability. The antitumor activity of the drug was mediated by the selective activation of mitogen-activated protein kinases in a cell-specific manner and was neutralized by their specific inhibitors. In vivo treatment with GIT-27NO significantly reduced the B16 melanoma growth in syngeneic C57BL/6 mice. The therapeutic effect occurred at dose (0.5 mg/mouse) up to 160 times lower than those needed to induce acute lethality (80 mg/mouse). In addition, a dose of GIT-27NO five times higher than that found effective in the melanoma model was well tolerated by the mice when administered for 4 consecutive weeks. These data warrant additional studies to evaluate the possible translation of these findings to the clinical setting. 相似文献
104.
Palese A Beltrame ER Bin A Borghi G Bottacin M Buchini S Buffon ML Carniel G Dal Bo' O De Caneva S De Lucia P Della Bianca S Drusian M Gasti M Giacomuzzi P Labelli E Lavia B Masala O Moretto G Pordenon M Santarossa A Sut A Tomietto M Valoppi G Zorzi MC Guardini I Mesaglio M Vesca R Sbaiz D Salmaso D 《Assistenza infermieristica e ricerca : AIR》2008,27(1):33-42
105.
106.
107.
Alexis Nobileau MD Rahul Gaurav MS PhD Lydia Chougar MD Alice Faucher MD Romain Valabrègue PhD Graziella Mangone MD PhD Smaranda Leu-Semenescu MD François-Xavier Lejeune PhD Jean-Christophe Corvol MD PhD Isabelle Arnulf MD PhD Marie Vidailhet MD David Grabli MD PhD Bertrand Degos MD PhD Stéphane Lehéricy MD PhD 《Movement disorders》2023,38(3):479-484
Background
The locus coeruleus/subcoeruleus complex (LC/LsC) is a structure comprising melanized noradrenergic neurons.Objective
To study the LC/LsC damage across Parkinson's disease (PD) and atypical parkinsonism in a large group of subjects.Methods
We studied 98 healthy control subjects, 47 patients with isolated rapid eye movement sleep behavior disorder (RBD), 75 patients with PD plus RBD, 142 patients with PD without RBD, 19 patients with progressive supranuclear palsy (PSP), and 19 patients with multiple system atrophy (MSA). Twelve patients with MSA had proven RBD. LC/LsC signal intensity was derived from neuromelanin magnetic resonance imaging using automated software.Results
The signal intensity was reduced in all parkinsonian syndromes compared with healthy control subjects, except in PD without RBD. The signal intensity decreased as age increased. Moreover, the signal intensity was lower in MSA than in isolated RBD and PD without RBD groups. In PD, the signal intensity correlated negatively with the percentage of REM sleep without atonia. There were no differences in signal intensity between PD plus RBD, PSP, and MSA.Conclusions
Neuromelanin signal intensity was reduced in all parkinsonian disorders, except in PD without RBD. The presence of RBD in parkinsonian disorders appears to be associated with lower neuromelanin signal intensity. Furthermore, lower LC/LsC signal changes in PSP could be partly caused by the effect of age. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. 相似文献108.
109.
Bruno G Merletti F Bargero G Melis D Masi I Ianni A Novelli G Pagano G Cavallo-Perin P 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2008,18(1):39-45
Background and aimsIn this study we assessed the prevalence of diagnosed type 2 diabetes and the quality of care during the period 1988–2000 in an Italian population.Methods and resultsTwo population-based surveys, using similar methods and centralized measurements, were conducted in 1988 and 2000 in a representative Italian area to identify people with known diabetes. The adjusted prevalence (reference, 2001 Italian population) was computed. The age- and sex-adjusted prevalence rates of diabetes in the population of Casale Monferrato were 2.13% (2.05–2.22) in 1988 and 3.07% (2.97–3.17) in 2000. In comparison with diabetic persons recruited in 1988 and independently of age and sex, persons recruited in 2000 had a lower likelihood of having HbA1c ≥7.0% (OR = 0.48; 0.42–0.56), diastolic blood pressure ≥80 mmHg (OR = 0.61; 0.49–0.75), LDL cholesterol ≥2.59 mmol/l (OR = 0.77; 0.63–0.93) and AER ≥20 μg/min (OR = 0.53; 0.45–0.61; they had a higher likelihood of having BMI ≥25 kg/m2 (OR = 1.49; 1.2–1.74). However, 45.4% of patients still had HbA1c ≥7.0%, 80% blood pressure ≥130/80 mmHg and 79% LDL-cholesterol values ≥2.59 mmol/l.ConclusionMore than two-thirds of Italians with diabetes are now aged 65 years and more. The quality of control of glycemia, lipids and blood pressure improved and the prevalence of diabetic nephropathy decreased over time, although complete adherence to international guidelines has not yet been achieved. 相似文献